fda tirzepatide update approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Speak up and share your

A recent study that illustrates this well discussed the potential of these drugs as treatments for chronic inflammatory skin disease hidradenitis suppurativa (HS)

HR: 0.73) and BRVO (HR: 0.62) over five years compared to DPP-4 inhibitor use

doi: 10.1111/acel.2016.15.issue-6 158 LardenoijeRVan Den HoveDLAVaessenTSJIatrouAMeuwissenKPVVan HagenBTJet al

It can safely rejuvenate thin skin under the eyes or smooth lines near the mouth without damaging nearby tissue

Talk to your doctor about these potential side effects and how to avoid or limit them

Recent clinical trials suggest that chelating iron with the brain-penetrant agent deferiprone can worsen symptoms, especially in patients who have not yet initiated dopaminergic therapy